SCHEMBL25002958

SCHEMBL25002958

COc1cc(/C=N/NC(=O)c2ccnc(-c3ccc(OC4CCCC4)cc3)c2)cc(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ MGAM O43451 1/20 0.47
▸ LMNA P02545 3/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 4/20 0.44
▸ RAB9A P51151 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ KDM1A O60341 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ TP53 P04637 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30171377 1.00 MAPT (0.52) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL27237434 1.00 MAPT (0.52) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL27237474 0.88 MGAM (0.55) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL25003149 0.88 MGAM (0.55) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL30862201 0.86 ALDH1A1 (0.50) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL25002954 0.86 ALDH1A1 (0.50) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL27237475 0.86 ALDH1A1 (0.50) MAPTSMN1; SMN2MGAMLMNAKMT2A
SCHEMBL25003166 0.85 FDPS (0.47) MAPTSMN1; SMN2MGAMKMT2AMEN1
SCHEMBL30951018 0.85 FDPS (0.47) MAPTSMN1; SMN2MGAMKMT2AMEN1
SCHEMBL27237391 0.85 FDPS (0.47) MAPTSMN1; SMN2MGAMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
CN-118076347-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 — — CN claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
CN-118076347-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 — — CN disclosed
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback